suntimes
TOUGH 
Weather Updates

Stocks edge higher on consumer spending data

The stock market finished mostly lower Thursday as investors assessed latest batch company earnings sold utility energy stocks. | AP

The stock market finished mostly lower on Thursday as investors assessed the latest batch of company earnings and sold utility and energy stocks. | AP file photo

storyidforme: 64170540
tmspicid: 22900035
fileheaderid: 11097338

Updated: March 28, 2014 4:05PM



NEW YORK — A positive report on U.S. consumer spending helped push stocks mostly higher Friday for the first time in three days.

The gains were modest as investors continued to cut their holdings in biotechnology stocks, some of the best performing names of 2013. Instead, the stocks that advanced the most were mostly mature, large companies such as Microsoft, Exxon and Cisco Systems.

The Dow Jones Industrial average rose 58.83 points, or 0.4 percent, to 16,323.06. The Standard & Poor’s 500 index rose 8.58 points, or 0.5 percent, to 1,857.62. The Nasdaq composite, which includes a number of large biotech companies, rose just 4.53 points, or 0.1 percent, to 4,155.76.

The biggest gainer in the Dow was Microsoft, which rose 94 cents, or 2.4 percent, to $40.30. The company announced Thursday that it was bringing Microsoft Office to the iPad and would shift its focus away from Windows, a move that analysts liked. Satya Nadella made the announcement in his first public appearance as the new leader of Microsoft.

“We continue to view (Office on the iPad) as a massive revenue and operating profit opportunity for Microsoft,” analysts at Credit Suisse said in a report Thursday.

Microsoft helped lift other large technology companies, with Cisco Systems, Intel and Oracle up roughly 1 percent or more.

In contrast to technology, biotechnology had another horrible day. Gilead Sciences, Biogen Idec and Vertex Pharmaceuticals were all down 4 percent or more.

The higher they rise, the harder they fall, investors say. Biotechnology stocks had been among the hottest sectors in the stock market for the last two years, with the S&P 500 Biotechnology index rising 74 percent in 2013 and 38 percent in 2012.

That momentum stopped dead in the month of March. The S&P 500 Biotechnology index is down 12 percent this month alone, erasing all of the sector’s gains in January and February.

The sell-off in biotech echoes the pullback investors have seen speculative technology stocks, such as Twitter, Netflix and Tesla Motors. Those stocks are down between 14 percent and 20 percent this month alone.

“The high-momentum names have lost all the traction they had in the past year,” said John Fox, director of research at Fenimore Asset Management.

Investors were encouraged by news that Americans increased their spending last month, a hopeful sign for an economy that has been slowed by months of severe winter weather. The Commerce Department said consumer spending inched up 0.3 percent, a hair short of economists’ forecasts. Incomes rose at the same pace.

“The economy is now reaching the point where it can shake off the weather-related excuses,” Doug Cote, a market strategist for ING Investment Management, wrote in an email.

Investors will now turn their attention to next week’s economic data, including the March jobs report due out Friday. Economists expect the U.S. economy, thawing from the harsh winter, created 200,000 jobs last month and the unemployment rate remained steady at 6.6 percent.

In other markets, the yield on the 10-year Treasury note hovered around 2.72 percent, up from 2.69 percent Thursday. The price of crude oil edged up 39 cents, or 0.4 percent, to $101.67 a barrel. Gold was little changed at $1,293.80 an ounce.



© 2014 Sun-Times Media, LLC. All rights reserved. This material may not be copied or distributed without permission. For more information about reprints and permissions, visit www.suntimesreprints.com. To order a reprint of this article, click here.